Overview
GLP-1 receptor agonist. Increases insulin secretion, blunts appetite, slows gastric emptying. Originally developed for type 2 diabetes; now the dominant peptide in the fat-loss landscape. Provided here as research/laboratory reference.
Reported Dosing Ranges
Reference information only. Not medical advice, prescriptions, or recommendations.
Fat Loss / Glycemic Support (research reference)
Dosage
0.25-1.0 mg
Frequency
Once weekly
Cycle Length
12 weeks
Timing
Any time of day; consistent weekly
Notes
Subcutaneous abdomen or thigh. Start 0.25 mg/wk for 4 weeks, double every 4 weeks if tolerated. Approved consumer products (Ozempic, Wegovy) require a prescription.
Reconstitution Calculator
* U-30 recommended for this dose (5.0 units)
Your Dose
Draw to
5.0units
(0.050 mL) on a U-100 syringe
Syringe Fill
U-100 insulin syringe
Reconstitution
Concentration
5.00 mg/mL
mcg per mL
5000 mcg
Per Unit (IU)
50.0 mcg
Doses Per Vial
20 doses
Storage
🌡️ Refrigerate at 2-8°C
📋 Stable ~30 days reconstituted.
⏱️ Shelf life: 30 days after reconstitution